Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ladan Fazli

Showing results (21-30 of 270) with videos related to

Pageof 27
Sort By:
Cancer Research|October 15, 2013
Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implicationsLaurent Grosse, Sophie Pâquet, Patrick Caron, et al.
Molecular Cancer Therapeutics|July 24, 2009
Intravesical combination treatment with antisense oligonucleotides targeting heat shock protein-27 and HTI-286 as a novel strategy for high-grade bladder cancerYoshiyuki Matsui, Boris A Hadaschik, Ladan Fazli, et al.
BJU International|August 2, 2006
Small interference RNA targeting heat-shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase-3 activation in vitroPalma Rocchi, Paul Jugpal, Alan So, et al.
Cancer Research|March 4, 2010
Hsp27 promotes insulin-like growth factor-I survival signaling in prostate cancer via p90Rsk-dependent phosphorylation and inactivation of BADAmina Zoubeidi, Anousheh Zardan, Romina M Wiedmann, et al.
Investigational New Drugs|April 3, 2018
Autophagy inhibition improves the chemotherapeutic efficacy of cruciferous vegetable-derived diindolymethane in a murine prostate cancer xenograft modelHossam Draz, Alexander A Goldberg, Emma S Tomlinson Guns, et al.
BJU International|May 12, 2006
Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genesKazuki Yamanaka, Palma Rocchi, Hideaki Miyake, et al.
Computers in Biology and Medicine|October 30, 2020
Improving prostate cancer classification in H&E tissue micro arrays using Ki67 and P63 histopathologyYanan Shao, Guy Nir, Ladan Fazli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2011
A novel HSP90 inhibitor delays castrate-resistant prostate cancer without altering serum PSA levels and inhibits osteoclastogenesisFrancois Lamoureux, Christian Thomas, Min-Jean Yin, et al.
Molecular Cancer Therapeutics|November 9, 2005
A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cellsKazuki Yamanaka, Palma Rocchi, Hideaki Miyake, et al.
Cancer Research|November 3, 2007
Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activityAmina Zoubeidi, Anousheh Zardan, Eliana Beraldi, et al.
Pageof 27

Showing results (21-30 of 270) with videos related to

Sort By:
Pageof 27
Cancer Research|October 15, 2013
Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implicationsLaurent Grosse, Sophie Pâquet, Patrick Caron, et al.
Molecular Cancer Therapeutics|July 24, 2009
Intravesical combination treatment with antisense oligonucleotides targeting heat shock protein-27 and HTI-286 as a novel strategy for high-grade bladder cancerYoshiyuki Matsui, Boris A Hadaschik, Ladan Fazli, et al.
BJU International|August 2, 2006
Small interference RNA targeting heat-shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase-3 activation in vitroPalma Rocchi, Paul Jugpal, Alan So, et al.
Cancer Research|March 4, 2010
Hsp27 promotes insulin-like growth factor-I survival signaling in prostate cancer via p90Rsk-dependent phosphorylation and inactivation of BADAmina Zoubeidi, Anousheh Zardan, Romina M Wiedmann, et al.
Investigational New Drugs|April 3, 2018
Autophagy inhibition improves the chemotherapeutic efficacy of cruciferous vegetable-derived diindolymethane in a murine prostate cancer xenograft modelHossam Draz, Alexander A Goldberg, Emma S Tomlinson Guns, et al.
BJU International|May 12, 2006
Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genesKazuki Yamanaka, Palma Rocchi, Hideaki Miyake, et al.
Computers in Biology and Medicine|October 30, 2020
Improving prostate cancer classification in H&E tissue micro arrays using Ki67 and P63 histopathologyYanan Shao, Guy Nir, Ladan Fazli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2011
A novel HSP90 inhibitor delays castrate-resistant prostate cancer without altering serum PSA levels and inhibits osteoclastogenesisFrancois Lamoureux, Christian Thomas, Min-Jean Yin, et al.
Molecular Cancer Therapeutics|November 9, 2005
A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cellsKazuki Yamanaka, Palma Rocchi, Hideaki Miyake, et al.
Cancer Research|November 3, 2007
Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activityAmina Zoubeidi, Anousheh Zardan, Eliana Beraldi, et al.
Pageof 27